Eurosets Starts U.S. Commercialization of New Oxygenators

Eurosets has begun commercializing its Trilly and Horizon oxygenators in the United States, having earned U.S. Food and Drug Administration (FDA) 510(k) clearance.

Equipped with an integrated stainless-steel heat exchanger and fully coated with Phosphorylcholine, both devices are designed for cardiopulmonary bypass procedures lasting up to six hours. Trilly is optimized for smaller patients requiring up to 3.5 L/min blood flow while Horizon is intended for adult and small-sized adult patients needing up to 7.0 L/min blood flow.

“We are excited to begin serving the U.S. perfusion community with Trilly and Horizon,” said Davide Ariosto, director of Global Sales and president of North America, Eurosets. “Our collaboration with the FDA to bring these initial products to the U.S. market has been a positive experience, and we look forward to continued success for additional products in our Cardiopulmonary suite. At Eurosets, we are driven by a simple belief: every patient—from newborns to adults—deserves the best possible chance, whether in the hospital or in the field.”

Concurrently with the Trilly and Horizon market release, Eurosets has forged an exclusive U.S. distribution partnership with Orion Medical (Detroit), a provider of advanced medical/simulation device distribution and data-driven clinical solutions.

“Our exclusive partnership with Eurosets marks an exciting and pivotal moment for Orion Medical,” stated Jeff Hanna, U.S. national sales director. “We are committed to supporting cardiac surgery and intensive care centers across the U.S. with technologies that are reliable, advanced, and sustainable. Orion Medical and Eurosets share a conviction that continuous innovation, service excellence, and data-powered insights are essential to improving outcomes for critically ill patients.”

Eurosets is an Italian manufacturing company specializing in cardiopulmonary, ECLS (extracorporeal life support), and wound and blood management solutions. The company can produce approximately 500 oxygenators, 700 arterial filters, and 2000 drop filters daily over two work shifts.